Deborah Farr, M.D. is a surgical oncologist who specializes in treating breast cancer. When Dr. Farr heard about Olivia Munn’s diagnosis, she immediately knew what tool gave her the lifesaving information that she needed. “The breast cancer risk assessment tool…
Tag: Cancer
UC Irvine-led research team discovers role of key enzymes that drive cancer mutations
A research team led by the University of California, Irvine has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new targets for intervention strategies.
Yale Cancer Center experts present new research on obesity, tobacco, evolution, and early onset cancers at leading oncology conference
Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.
New Research in March: Colorectal Cancer, Kidney Health, OR Supply Costs, and More
The March issue of the Journal of the American College of Surgeons (JACS) features new research on topics ranging from colorectal cancer and social vulnerability to operating room supply costs, the rise in school shootings since 1970, and the impact of permitless open carry laws on suicide rates, among others.
A soja aumenta o risco de câncer de mama?
A pergunta está gerando muitos debates. Há alguma conexão entre a soja e o câncer de mama? A soja contém isoflavonas, que são estrogênios vegetais. Os níveis elevados de estrogênio estão vinculados com os riscos de câncer de mama. Entretanto, há estudos que demonstram que os produtos de soja não contêm níveis suficientemente elevados de estrogênio para aumentar as chances de desenvolvimento de câncer de mama.
Breast Cancer Diagnoses Plummeted During First Year of Pandemic
There was a 15-20% decrease in newly diagnosed breast cancer cases reported to American College of Surgeons Commission on Cancer sites in 2020 compared to 2019.
¿La soja aumenta el riesgo de cáncer de mama?
Ha generado varios debates. ¿Hay alguna conexión entre la soja y el cáncer de mama? La soja contiene isoflavonas, que son los estrógenos vegetales. Se han relacionado los niveles altos de estrógeno con un mayor riesgo de cáncer de mama. Sin embargo, hay estudios que demuestran que los productos de soja no contienen niveles de estrógeno lo suficientemente altos como para aumentar las probabilidades de desarrollar cáncer de mama.
Smoking Is an Undertreated Risk Factor After a Cancer Diagnosis
Baseline survey results of a national quality improvement project led by the American College of Surgeons describe the many challenges and missed opportunities these centers may face when trying to help patients quit smoking.
APOLLO researchers uncover new target for ovarian cancer treatment
Scientists have identified a new target in ovarian cancer that is particularly vulnerable to chemotherapy. The discovery will allow researchers to better predict how this cancer will behave, particularly the most common and lethal, high-grade serous ovarian cancer (HGSOC). Ovarian cancer is one of the leading causes of cancer deaths among women.
Robotic surgery expertise increases odds for those who battle stomach cancer like Toby Keith
Toby Keith, John Wayne and Fred Rogers are among many famous figures who passed from stomach cancer, a particularly deadly form of cancer. Now, robotic surgery is improving the odds for cancer patients. Matthew Porembka, M.D. is part of a…
MILITARY MEMBERS MORE AT RISK FOR MELANOMA
U.S. veterans are at a higher risk of developing melanoma, one of the deadliest forms of skin cancer, likely due in part to the occupational hazards associated with active duty in countries near the equator where ultraviolet (UV) levels are higher.
Launch of a pioneering translational research programme in Europe
– The TRIP initiative establishes three new joint laboratories that bring together fundamental biomedical research and clinical research with the aim of accelerating the delivery of results to patients.
– TRIP will focus on emerging fields such as immuno-oncology, inflammation, and cellular senescence.
Call for Papers and Participation: Joint International Conference on ‘Cutting-edge Nanotechnologies for Good Health and Well-being’
The Faculty of Medicine at Chulalongkorn University, cordially invites all those who are interested to attend the joint international conference on “CUTTING-EDGE NANOTECHNOLOGIES FOR GOOD HEALTH AND WELL-BEING” from July 9-12, 2024 between 8:00 and 18:00 hrs. at Chulalongkorn University and Mandarin Hotel, Bangkok, Thailand.
Case Western Reserve University-led research team discovers new method to test for oral cancer
A team of researchers, led by a clinician scientist at the Case Western Reserve University School of Dental Medicine, has discovered a noninvasive, low-cost test to detect oral cancer, monitor precancerous lesions and determine when a biopsy is warranted.
Baylor Scott & White doctor discusses why cancer is impacting more young people
David Winter, MD, at Baylor Scott & White Health, discusses why cancer is impacting more young people. What You Need to Know: People aged 50 and older are living longer because of better cancer detection and treatments. Cancer diagnosis in…
Cell Division, DNA Repair, and Cancer Progression Closely Tied to CDK9 Dysfunction
Researchers describe a newly-observed role for the protein Cyclin Dependent Kinase 9 (CDK9) in regulating DNA repair during cellular division, where errors can become the origin of cancerous tumor growth.
Cleveland Clinic Researchers Uncover How Virus Causes Cancer, Point to Potential Treatment
Cleveland Clinic researchers have discovered a key mechanism used by Kaposi’s sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8), to induce cancer. The research points to effective new treatment options for KSHV-associated cancers, including Kaposi’s sarcoma, primary effusion lymphoma, and HHV8-associated multicentric Castleman disease.
Less chemoradiation is possible for some cancer patients
Scaling back treatment can mean better quality of life for oropharynx cancer patients who qualify
Targeted drug shows promising ability in treating rare head and neck cancers
Experts at Rogel Cancer Center develop and study the impact of a new drug for salivary gland cancers
LJI welcomes new faculty member Miguel Reina-Campos, Ph.D.
Cancer researcher Miguel Reina-Campos, Ph.D., has joined the faculty of La Jolla Institute for Immunology (LJI) as an Assistant Professor to lead the Laboratory of Tissue Immune Networks. His laboratory at LJI aims to investigate the basis of CD8+ T cell tissue immunity to improve life-saving cancer immunotherapies.
New model of key brain tumor feature could help scientists understand how to develop new treatments
Researchers at the University of Michigan Health Rogel Cancer Center are exploiting a unique biological feature of glioblastoma to gain a better understanding of how this puzzling brain cancer develops and how to target new treatments against it. The team developed human and mouse models of glioblastoma oncostreams and examined multiple factors in the tumor microenvironment that could impact how oncostreams develop and how to reverse them.
Five Signs of Colorectal Cancer You Shouldn’t Ignore – Even if You’re a Younger Adult
The recent Cancer Facts & Figures 2024 report from American Cancer Society (ACS) researchers revealed a stark increase in colorectal cancer (CRC) incidence among Americans under the age of 55. In just two decades, CRC has moved up from being the fourth leading cause of cancer death in both younger men and women, to first in men and second in women.
Turbocharging CRISPR to Understand How the Immune System Fights Cancer
Harvard Medical School scientists develop new CRISPR-based tool to study the immune function of genes.
New gene-editing approach could optimize how scientists study the immune system’s role in cancer and other immune-mediated diseases.
Data-processing tool could enable better early stage cancer detection
Cancers begin with abnormal changes in individual cells, and the ability to track the accumulation of mutations at the single-cell level can shed new light on the early stages of the disease
Long-term survivors of childhood cancer at higher risk of death following heart issues; threshold for treating risk factors should be lower
New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indicates that survivors of childhood cancer are at a significantly higher risk of death following a major cardiovascular event — including heart failure, heart attack or stroke — than the general public.
Sniffing our way to better health
Imagine if we could inhale scents that delay the onset of cancer, inflammation, or neurodegenerative disease. Researchers at the University of California, Riverside, are poised to bring this futuristic technology closer to reality.
Remote online genetic education programs can spur testing for inherited susceptibility to cancer, study suggests
In the GENERATE study, 90% of those who viewed an online genetic education program chose to be tested for inherited predisposition to pancreatic cancer.
Case Western Reserve receives NIH funding to study long-term health effects of East Palestine, Ohio, train derailment
The National Institutes of Health (NIH) has awarded researchers at Case Western Reserve University a grant to begin studying the possible long-term health effects of exposure to hazardous chemicals from the East Palestine, Ohio, train derailment.
Clinical trial tests combination antibody therapy in adults with advanced cancer
In an early phase clinical trial, a combination of antibody-based medications targeting the immune system generated promising safety data and anti-tumor activity in individuals with various types of advanced cancer.
Roswell Park Study First to Show Two-Drug Combination Selectively Targets p53-Mutant Cancers
A preclinical study led by a team of researchers at Roswell Park Comprehensive Cancer Center highlights the potential of a novel two-drug treatment strategy targeting p53-mutant cancers.
Dana-Farber and Gustave Roussy to hold third Transatlantic Exchange: Annual scientific conference dedicated to advancing Oncology research and practice
Dana-Farber Cancer Institute (Boston, MA, USA) and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the third Transatlantic Exchange in Oncology Conference will address: Liquid Biopsy as an Emerging Approach in Precision Cancer Medicine.The meeting, supported by L’Institut Servier, will be held in-person (witha virtual attendance option) on April 12, 2024, at the Revere Hotel Boston Common and livestreamed virtually on Medscape’s platform.
Markey study shows expanded cancer gene testing feasible, beneficial for patients
A new University of Kentucky Markey Cancer Center study published in JCO Precision Oncology demonstrates a feasible way to expand germline genetic testing for patients with cancer.
People With Incarceration History Less Likely to Receive Health Care, Including Cancer Screening in the U.S.
A new study led by researchers at the American Cancer Society (ACS) shows people with an incarceration history had worse access to and receipt of healthcare, including physical exams, blood pressure, blood sugar and cholesterol tests, as well as dental check-ups and breast and colorectal cancer screenings compared with people without incarceration history in the United States. The findings are published today in the Journal of the American Medical Association (JAMA) Health Forum.
MD Anderson acquires inducible switch technologies for cell therapy
MD Anderson has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDE switch and GoCAR platforms. As a result, MD Anderson may incorporate these technologies into its own cell therapy programs as well as make them available for licensing to interested parties.
Researchers makes promising discoveries on role of vitamin B6 in pancreatic cancer
Vitamin B6 is beneficial in many ways, notably for its role in maintaining a strong immune system.
Chronic stress spreads cancer … here’s how
Stress is inevitable. But too much of it can be terrible for our health. Chronic stress can increase our risk for heart disease and strokes. It may also help cancer spread. How this works has remained a mystery—a challenge for cancer care.
UK Markey Cancer Center study reveals extent of undiagnosed cancer cases caused by pandemic
Over 134,000 cancer cases went undiagnosed in the U.S. during the first 10 months of the COVID-19 pandemic, according to a new University of Kentucky Markey Cancer Center study.
Kidney cancer treatments and tumor biology can activate different immune-modifying processes in patients
The findings out of Dana-Farber Cancer Institute highlight that the mechanisms of immune modulation are different in patients treated with immunotherapy and anti-angiogenic combinations. The results also point to the role of tumor biology in the diversity and actions of tumor-infiltrating immune cells brought into action by these treatments. The findings might be important for predicting or understanding treatment outcomes in advanced kidney cancer.
A Mount Sinai-Led Study Shows Early Success of a Novel Drug in Treating a Rare and Chronic Blood Cancer
Results of 16-Center REVIVE trial published in The New England Journal of Medicine
Uniformed Services University to Represent DoD in New Cancer Screening Research Network
To identify cancers earlier and better understand when they may be easier to treat, the National Cancer Institute (NCI), part of the National Institutes of Health, has launched a new clinical trials network to evaluate emerging technologies for cancer screening.
UNC Lineberger named as a national research hub for NIH cancer screening study
UNC Lineberger Comprehensive Cancer Center has been selected as one of nine national research sites for the National Cancer Institute’s newly launched Cancer Screening Research Network, which will evaluate promising and emerging cancer screening technologies.
Stemming colorectal cancer in Latin America
Little is known about colorectal cancer screening strategies throughout the Western Hemisphere, with the exception of the U.S. and Canada.
U of T-led study finds positive support from parents and clinicians for pediatric cancer pain management app
A recent study led by Assistant Professor Lindsay Jibb of the Lawrence Bloomberg Faculty of Nursing and Scientist at The Hospital for Sick Children (SickKids) found that parents of young children with cancer, along with pediatric cancer clinicians are in favour of an app-based solution that Jibb and her team are creating, to help parents manage their child’s cancer pain at home.
Avanço no tratamento do câncer de pâncreas com cirurgia robótica total de Whipple
As novas tecnologias estão melhorando o tratamento do câncer de pâncreas, oferecendo esperança aos pacientes que enfrentam uma das formas de câncer mais letais. O procedimento de Whipple, uma cirurgia complexa para o câncer de pâncreas localizado, agora pode ser feito roboticamente.
New cell-based immunotherapy offered for melanoma
Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
Avance en el tratamiento del cáncer de páncreas con cirugía robótica total de Whipple
Las nuevas tecnologías están mejorando el tratamiento del cáncer de páncreas, ofreciendo esperanza a los pacientes que enfrentan una de las formas de cáncer más letales. El procedimiento de Whipple, una cirugía compleja para el cáncer de páncreas localizado, ahora se puede hacer robóticamente.
National Breast Cancer Foundation Gives Grant to Help Breast Care Center Patients at Texas Tech Physicians of El Paso
In addition to assisting with access to care, such as transportation and general needs like groceries, the grant will allow the Breast Care Center to screen for mental and emotional distress using tablets. Currently, patients participate in an online distress screening survey that prompts questions about financial and psychosocial stressors in a patient’s life.
Giant step forward to help treat chronic wounds that affect millions
A team of international scientists has developed a more effective treatment for chronic wounds that does not involve antibiotics or silver-based dressings, but an ionized gas called plasma.
In Memoriam: Jonathan W. Uhr, M.D., renowned immunologist and longtime Chair of Microbiology
Jonathan W. Uhr, M.D., Professor Emeritus of Immunology at UT Southwestern Medical Center, who discovered how antibodies are made and developed a technique that led to the early detection of cancer cells, died Feb. 15. He was 96. Dr. Uhr was a member of the National Academy of Sciences and the American Academy of Arts and Sciences.
The Center to Eliminate Cancer Inequity to address unequal burden of cancer driven by health disparities
A new center at the University of Chicago Medicine will provide strategic leadership to bring together researchers, healthcare providers and community members to eliminate Chicago’s chronic cancer disparities.